New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 4, 2013
07:41 EDTTHOR, HTWRCorrection: Thoratec attractive on any post-guidance weakness, says Oppenheimer
Oppenheimer reports that Thoratec (THOR) will provide 2013 guidance on February 5, and the firm adds that the company has traditionally been conservative with its first outlook of the year. Oppenheimer thinks the stock may be muted in the near-term but it believes that the shares will have a number of positive catalysts later in the year. It recommends buying the shares on any pullbacks. A previous note incorrectly stated that this note from Oppenheimer was written about HeartWare (HTWR).
News For THOR;HTWR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 27, 2015
07:40 EDTHTWRHeartWare price target raised to $105 from $90 at Leerink
Subscribe for More Information
February 26, 2015
07:03 EDTHTWRHeartWare reports 737 HeartWave Ventricular Assist Systems sold globally
U.S. revenue, generated through the sale of 382 units during the fourth quarter of 2014, was $41.5 million, a 60% increase from $25.9 million in the fourth quarter of 2013.
07:02 EDTHTWRHeartWare reports Q4 non-GAAP EPS (41c), consensus (59c)
Subscribe for More Information
February 23, 2015
07:28 EDTHTWRHeartWare recall should not have material impact long-term, says Canaccord
Canaccord does not believe the voluntary recall issued by HeartWare should not have any material impact on its business long-term, as the serious event rate is relatively low. The recall pertains to a previously known issue and is in effect a continuation of its 2013 corrective action, Canaccord said. The firm reiterated its Buy rating and $115 price target on HeartWare shares.
February 20, 2015
16:35 EDTHTWRHeartWare issues recall of older HeartWare clinical trial controllers
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use